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Cardiovascular disease is one of the main causes of 
death in the industrialized society. In 2009, 87.534 
and 17.583 patients were hospitalized in the Nether-
lands for treatment of ischemic heart disease and pe-
ripheral arterial disease, respectively. In both patient 
populations, the mortality rates are approximately 
12 % (1). For the treatment of cardiovascular disease, 
 functional vascular grafts with an inner diameter less 
than 6 mm are needed. The availability and quality 
of autologous bypass grafts (e.g. mammary artery, 
saphenous vein) is frequently limited, especially in 
elderly patients. Although synthetic vascular grafts 
made from the polymers Dacron or Teflon perform 
reasonably well in large-diameter applications, these 
prostheses fail in small-diameter reconstructions due 
to thrombus formation and intima hyperplasia, ham-
pering successful treatment of these patients.
Vascular tissue engineering
As shown during the last 10-15 years, tissue engi-
neering is a promising technique to prepare func-
tional small-diameter arterial grafts. Vascular smooth 
muscle cells (SMCs) of the patient are cultured and 
subsequently seeded in biodegradable porous tubular 
scaffolds. The resulting constructs are mounted in a 
pulsatile flow bioreactor and perfused for a period 
up to several weeks, during which the medial layer 
of the graft develops. Subsequently, autologous endo-
thelial cells (ECs) are seeded on the luminal surface, 
after which the grafts are perfused for an additional 
period of several days (2). In alternative procedures, 
autologous stem cells have been used (e.g. mesenchy-
mal stem cells from bone marrow). Moreover, for low 
pressure reconstructions such as the pulmonary artery, 
constructs have been implanted immediately after 
mesenchymal stem cell seeding (3).
The ideal scaffold for vascular tissue engineering is 
biocompatible, flexible, elastic and biodegradable. To 
facilitate formation of the medial layer of the graft, 
the pore structure should be interconnected to provide 
a three-dimensional space for adhesion, proliferation 
and differentiation of the cells, and to allow diffusion 
of nutrients and metabolic waste products. Moreover, 
the scaffold should maintain suitable mechanical 
properties until maturation of the newly formed vas-
cular tissue (4, 5). The pulsatile flow bioreactor has 
to mimic the blood circulation in terms of flow rate, 
pressure and pulse frequency. The constructs are per-
fused with culture media optimized for the culturing 
of SMCs and ECs, respectively. In the case of stem cell 
seeding, the culture media can be supplemented with 
appropriate differentiation factors.
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Figure 1. Scanning electron microscopy images of a collagen/
elastin scaffold (top) and a PTMC scaffold (bottom).
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Approximately 10 years ago, we started with vascular 
tissue engineering using scaffolds prepared from col-
lagen and elastin (6-8). These proteins are key compo-
nents of the extracellular matrix in the natural vessel 
wall. Suspensions of collagen and elastin (1:1 w/w) 
were freeze-dried in annular molds, yielding tubular 
scaffolds with an inner diameter of 3 mm and with pore 
sizes of 130-150 μm and a porosity of 90 % (figure 1). 
To improve the mechanical properties, the scaffolds 
were cross-linked by means of a non-cytotoxic method 
introducing intermolecular peptide bonds. SMCs from 
umbilical cords were seeded in the scaffolds using a 
filtration seeding method and subsequently cultured 
during 14 days under dynamic conditions in a pulsa-
tile flow bioreactor, or under stationary conditions as 
control. Dynamically cultured constructs contained 
2.5 times more SMCs and the cellular expression of 
collagen type I mRNA was 2-fold increased, as com-
pared to the controls. Only in the case of dynamic 
culturing, the SMCs were homogeneously distributed 
in the wall of the scaffolds. Although dynamic cultur-
ing significantly improved the mechanical properties 
of the constructs, the maximum strength in the radial 
direction was still 50-fold lower than that of a porcine 
carotid artery (9-12).
To improve the mechanical properties of the con-
structs, we started to use the synthetic polymer 
poly(trimethylene carbonate) (PTMC) as material for 
the preparation of scaffolds. PTMC shows excellent 
biocompatibility and is degraded in vivo by enzymatic 
surface erosion. Compliant and creep-resistant PTMC 
networks are obtained by means of γ-irradiation. Po-
rous tubular PTMC scaffolds can be formed by dip-
coating glass mandrels in a salt-containing polymer 
solution. After drying and subsequent leaching of 
the salt in water, an interconnected pore structure is 
obtained. In this way, tubular PTMC scaffolds were 
prepared with an inner diameter of 3 mm, an average 
pore size of 110 µm and a porosity of 85 %. To improve 
the cell seeding efficiency, a thin PTMC outer layer 
with a pore size of approximately 30 µm was dipped 
around the tubes (figure 1) (13,14). As determined by 
stress-strain measurements in the radial direction, 
these scaffolds were 10 times stronger than the col-
lagen-elastin scaffolds. Moreover, the compliance of 
the tubular PTMC scaffolds was the same as that of 
porcine carotid arteries (15).
Also in the PTMC scaffolds, human SMCs were 
seeded by means of a filtration seeding method, af-
ter which the constructs were cultured during 14 days 
in a pulsatile flow bioreactor. In this case, we used 
a computer-controlled bioreactor, perfusing the con-
structs at a shear rate of 350 s-1 and pressures of 70-130 
mm Hg at 70 pulses per minute (figure 2). Again, SMC 
numbers were significantly higher in dynamically cul-
tured constructs, as compared to stationary controls, 
and now the strength of the constructs in the radial 
direction approached that of the porcine carotid artery 
(construct 0.5 MPa, artery 1.5 MPa) (16).
In conclusion, we have prepared a potentially useful 
medial layer of a small-diameter vascular graft by 
means of a tissue engineering approach. Currently, we 
Figure 2. Overview of vascular tissue engineering. From left to right and top to bottom: tubular PTMC scaffold, SMC seeding, SMC-
containing construct, construct in flow chamber, pulsatile flow bioreactor.
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are investigating the endothelialization of the lumi-
nal surface of the constructs. Since extracellular ma-
trix proteins will be synthesized by the SMCs during 
dynamic culturing, it is anticipated that the luminal 
surface of the grafts is a good substrate for EC seed-
ing. After endothelialization, the performance of the 
grafts will be tested in a porcine carotid artery model. 
In addition to primary SMCs and ECs, we are also 
investigating the use of mesenchymal stem cells from 
adipose tissue. These cells can be obtained relatively 
easy in large quantities, and can be efficiently differ-
entiated into SMCs. Endothelial progenitor cells from 
peripheral blood may be a suitable cell source for auto-
logous ECs.
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